A carregar...
Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
Antipsychotics have been utilized as the standard treatment for schizophrenia regardless of illness phase where antipsychotic monotherapy (APM) is routinely recommended as the gold standard rather than antipsychotic polypharmacy (APP). However, approximately 20 to 40% of patients with schizophrenia...
Na minha lista:
| Publicado no: | Chonnam Med J |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Chonnam National University Medical School
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520369/ https://ncbi.nlm.nih.gov/pubmed/33014754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4068/cmj.2020.56.3.157 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|